Nora V Bergasa. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Alkaline Phosphatase/bloodAlkaline Phosphatase/drug effectsAntipruritics/therapeutic useAspartate Aminotransferases/bloodAspartate Aminotransferases/drug effectsBilirubin/bloodBiomarkers/bloodCholagogues and Choleretics/administration & dosageCholestyramine Resin/therapeutic useDose-Response Relationship, DrugEnzyme Inhibitors/administration & dosageEnzyme Inhibitors/adverse effectsHistory, 21st CenturyHumansLiver Cirrhosis, Biliary/bloodLiver Cirrhosis, Biliary/drug therapyPruritus/bloodPruritus/drug therapyRifampin/administration & dosageRifampin/adverse effectsSerum Albumin/metabolismUrsodeoxycholic Acid/administration & dosage
Substances： See more » AntipruriticsBiomarkersCholagogues and CholereticsEnzyme InhibitorsSerum AlbuminCholestyramine ResinUrsodeoxycholic AcidAspartate AminotransferasesAlkaline PhosphataseBilirubinRifampin
Year: 2003 PMID： 15017664
Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN： 1542-3565 Impact factor: 11.382